ZIM Lab Invests in Key Partnerships in Australia and MENA

ZIM Laboratories Limited (ZIM or the Company) has announced strategic investments in Australia and the MENA region to expand its presence in Developed and Pharmerging markets. For Australia and New Zealand markets, ZIM's Board has approved an investment in a local startup company to enhance its registration, marketing, distribution, and sales capabilities for New Innovative Products (NIP) and Oral Thin Films (OTF). The investment grants ZIM 99% ownership of the company.

In the MENA region, ZIM's subsidiary, ZIM Laboratories FZE, Sharjah, will invest and partner with a local experienced business entrepreneur, through a step-down majority owned subsidiary, to obtain regulatory approvals and facilitate marketing, distribution, and sales of its various products in specific regional markets. These initiatives signify the company's growth plans and its aim to introduce innovative products for expansion across new markets.

Shares of Zim Laboratories Ltd was last trading in BSE at Rs. 112.91 as compared to the previous close of Rs. 112.06. The total number of shares traded during the day was 20909 in over 325 trades.

The stock hit an intraday high of Rs. 115.30 and intraday low of 112.25. The net turnover during the day was Rs. 2370191.00.

Source : Equity Bulls

Keywords

ZimLaboratories INE518E01015 Pharmaceuticals Australia MENA StrategicInvestments